The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.

Sandset, Else Charlotte; Bath, Philip M W; Boysen, Gudrun; Jatuzis, Dalius; K�rv, Janika; L�ders, Stephan; Murray, Gordon D; Richter, Przemyslaw S; Roine, Risto O; Ter�nt, Andreas; Thijs, Vincent; Berge, Eivind; Peeters, André

doi:10.1016/S0140-6736(11)60104-9

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.

Sandset, Else Charlotte

;

Bath, Philip M W

;

Boysen, Gudrun

;

Jatuzis, Dalius

;

Peeters, André

;et.al.

(2011) The Lancet — Vol. 377, n° 9767, p. 741-750 (2011)

Files

2011-SCAST.pdf

Restricted Access
Adobe PDF
463.89 KB

Request a copy

Details

Authors

Sandset, Else Charlotte
Author
Bath, Philip M W
Author
Boysen, Gudrun
Author
Jatuzis, Dalius
Author
Peeters, AndréUCLouvain
Collaborator

Abstract

South-Eastern Norway Regional Health Authority; Oslo University Hospital Ullevål; AstraZeneca; Takeda.

Affiliations

Citations

APA
Chicago
FWB

Sandset, E. C., Bath, P. M. W., Boysen, G., Jatuzis, D., K�rv, J., L�ders, S., Murray, G. D., Richter, P. S., Roine, R. O., Ter�nt, A., Thijs, V., & Berge, E. (2011). The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. The Lancet, 377(9767), 741-750. https://doi.org/10.1016/S0140-6736(11)60104-9 (Original work published 2011)